Return On Equity of 10x Genomics, Inc. from 31 Dec 2018 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Summary
-
10x Genomics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2018 to 31 Dec 2025.
- 10x Genomics, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -5.7%, a 78% increase year-over-year.
- 10x Genomics, Inc. annual Return On Equity for 2025 was -5.7%, a 78% increase from 2024.
- 10x Genomics, Inc. annual Return On Equity for 2024 was -25%, a 23% increase from 2023.
- 10x Genomics, Inc. annual Return On Equity for 2023 was -33%, a 58% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
10x Genomics, Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -5.7% | +20% | +78% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -10% | +15% | +59% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -12% | +21% | +65% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -22% | +13% | +38% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -25% | +7.7% | +23% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -25% | +3.3% | +12% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -33% | -11% | -51% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -35% | -13% | -60% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -33% | -12% | -58% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -28% | -7.4% | -35% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -22% | -3.9% | -22% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -22% | -11% | -98% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -21% | -14% | -184% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -21% | +38% | +65% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -18% | +47% | +73% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -11% | +68% | +86% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -7.4% | +84% | +92% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -59% | -33% | -125% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | -65% | -46% | -242% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | -79% | -60% | -313% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -92% | -60% | -188% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | -26% | -187% | -116% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | -19% | -71% | -137% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | -19% | -75% | -134% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | -32% | -104% | -144% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | 161% | 01 Jul 2019 | 30 Sep 2019 | ||
| Q2 2019 | 52% | 01 Apr 2019 | 30 Jun 2019 | ||
| Q1 2019 | 56% | 01 Jan 2019 | 31 Mar 2019 | ||
| Q4 2018 | 72% | 01 Oct 2018 | 31 Dec 2018 |
10x Genomics, Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -5.7% | +20% | +78% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -25% | +7.7% | +23% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | -33% | -12% | -58% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -21% | -14% | -184% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -7.4% | +84% | +92% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -92% | -60% | -188% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -32% | -104% | -144% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | 72% | 01 Jan 2018 | 31 Dec 2018 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.